Glasser S - Search Results

1

A clustering analysis of lipoprotein diameters in the metabolic syndrome.

Frazier-Wood AC, Glasser S, Garvey WT, Kabagambe EK, Borecki IB, Tiwari HK, Tsai MY, Hopkins PN, Ordovas JM, Arnett DK. Frazier-Wood AC, et al. Among authors: glasser s. Lipids Health Dis. 2011 Dec 19;10:237. doi: 10.1186/1476-511X-10-237. Lipids Health Dis. 2011. PMID: 22182248 Free PMC article.

2

Lipoprotein lipase S447X variant associated with VLDL, LDL and HDL diameter clustering in the MetS.

Wood AC, Glasser S, Garvey WT, Kabagambe EK, Borecki IB, Tiwari HK, Tsai MY, Hopkins PN, Ordovas JM, Arnett DK. Wood AC, et al. Among authors: glasser s. Lipids Health Dis. 2011 Aug 19;10:143. doi: 10.1186/1476-511X-10-143. Lipids Health Dis. 2011. PMID: 21854610 Free PMC article.

3

High-fat meal effect on LDL, HDL, and VLDL particle size and number in the Genetics of Lipid-Lowering Drugs and Diet Network (GOLDN): an interventional study.

Wojczynski MK, Glasser SP, Oberman A, Kabagambe EK, Hopkins PN, Tsai MY, Straka RJ, Ordovas JM, Arnett DK. Wojczynski MK, et al. Lipids Health Dis. 2011 Oct 18;10:181. doi: 10.1186/1476-511X-10-181. Lipids Health Dis. 2011. PMID: 22008512 Free PMC article.

4

Smoking, inflammatory patterns and postprandial hypertriglyceridemia.

Kabagambe EK, Ordovas JM, Tsai MY, Borecki IB, Hopkins PN, Glasser SP, Arnett DK. Kabagambe EK, et al. Atherosclerosis. 2009 Apr;203(2):633-9. doi: 10.1016/j.atherosclerosis.2008.08.005. Epub 2008 Aug 13. Atherosclerosis. 2009. PMID: 18804210 Free PMC article.

5

TCF7L2 polymorphisms and inflammatory markers before and after treatment with fenofibrate.

Kabagambe EK, Glasser SP, Ordovas JM, Warodomwichit D, Tsai MY, Hopkins PN, Borecki IB, Wojczynski M, Arnett DK. Kabagambe EK, et al. Diabetol Metab Syndr. 2009 Oct 12;1(1):16. doi: 10.1186/1758-5996-1-16. Diabetol Metab Syndr. 2009. PMID: 19825152 Free PMC article.

6

Comparison of Postprandial Responses to a High-Fat Meal in Hypertriglyceridemic Men and Women before and after Treatment with Fenofibrate in the Genetics and Lipid Lowering Drugs and Diet Network (GOLDN) Study.

Glasser SP, Wojczynski MK, Oberman AI, Kabagambe EK, Tsai MY, Ordovas JM, Straka RJ, Arnett DK. Glasser SP, et al. SRX Pharmacol. 2010;2010:485146. doi: 10.3814/2010/485146. SRX Pharmacol. 2010. PMID: 24971173 Free PMC article.

7

Vascular stiffness and the "chicken-or-the-egg" question.

Glasser SP, Arnett DK. Glasser SP, et al. Hypertension. 2008 Feb;51(2):177-8. doi: 10.1161/HYPERTENSIONAHA.107.098830. Epub 2008 Jan 14. Hypertension. 2008. PMID: 18195167 No abstract available.

8

Subclinical, hemodynamic, and echocardiographic abnormalities of high pulse pressure in hypertensive and non-hypertensive adults.

Glasser SP, Krasikov T, Devereux RB, Oberman A, Patki A, Kitzman DW, Rao D, Arnett DK. Glasser SP, et al. Am J Cardiovasc Dis. 2012;2(4):309-17. Epub 2012 Oct 25. Am J Cardiovasc Dis. 2012. PMID: 23173105 Free PMC article.

9

Hemodynamic and echocardiographic profiles in African American compared with White offspring of hypertensive parents: the HyperGEN study.

Glasser SP, Lynch AI, Devereux RB, Hopkins P, Arnett DK. Glasser SP, et al. Am J Hypertens. 2014 Jan;27(1):21-6. doi: 10.1093/ajh/hpt178. Epub 2013 Nov 16. Am J Hypertens. 2014. PMID: 24242823 Free PMC article.

10

Pharmacogenetics of antihypertensive treatment.

Arnett DK, Claas SA, Glasser SP. Arnett DK, et al. Vascul Pharmacol. 2006 Feb;44(2):107-18. doi: 10.1016/j.vph.2005.09.010. Epub 2005 Dec 13. Vascul Pharmacol. 2006. PMID: 16356784 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

536 results

Search Page